期刊文献+

兔自体骨髓间充质干细胞移植联合激光心肌血运重建治疗急性心肌缺血 被引量:1

Rabbit autologous bone marrow mesenchymal stem cell transplantation combined with transmyocardial laser revascularization for treating acute myocardial ischemia
暂未订购
导出
摘要 背景:应用骨髓间充质干细胞移植修复坏死心肌,改善心脏功能已受到广泛关注。最近有报道指出激光具有促进骨髓间充质干细胞治疗心肌缺血的作用。目的:观察兔自体骨髓间充质干细胞移植联合激光心肌血运重建治疗急性心肌缺血的效果。设计、时间及地点:随机对照动物实验,于2006-01/07在安贞医院外科实验室完成。材料:成年雄性新西兰大白兔32只,随机分为4组:模型对照组、细胞移植组、激光组、联合组,8只/组。方法:造模前3d,经兔双侧胫骨穿刺抽取骨髓,经密度梯度离心和换液法分离纯化骨髓间充质干细胞,并行BrdU标记。各组兔均在全麻下结扎冠状动脉前降支建立急性心肌缺血模型,2周后,模型对照组在标记部位分3点注射0.6mLα-MEM培养基;细胞移植组同法注射等量第4代骨髓间充质干细胞悬液,细胞总数约3×106个;激光组应用高功率CO2治疗仪进行激光心肌打孔3个,功率为5J;联合组在标记点先行激光打孔,再在孔道周围心肌中层注射等量细胞悬液。主要观察指标:治疗4周后取出心脏,采用抗BrdU及抗肌钙蛋白T双重免疫组化染色检测骨髓间充质干细胞在梗死区心肌存活及分化情况,采用抗CD146免疫组化染色测定毛细血管密度,通过超声测定左室射血分数,通过计算心尖部位位移趋势及运动速度(应变)评价心肌阶段运动功能。结果:细胞移植组、联合组均检出岛状分布的双染阳性细胞,胞核呈黑色、胞浆呈棕色。与模型对照组比较,细胞移植组、激光组、联合组治疗区血管密度均显著增加(P均<0.05),且联合组增加幅度明显高于细胞移植组、激光组(P均<0.05),细胞移植组、激光组血管密度基本相似。与治疗前比较,治疗后4周细胞移植组、联合组左室射血分数、心尖段位移和应变值均明显改善(P<0.05),且与模型对照组、激光组比较差异有显著性意义(P<0.05)。结论:兔自体骨髓间充质干细胞可在心肌微环境内存活并分化为心肌样细胞,移植后联合激光心肌血运重建在增加心肌毛细血管密度方面优于单纯细胞移植或激光心肌血运重建治疗,在提高心脏功能方面的优势尚需进一步分析。 BACKGROUND: It has been widely paid attention that bone marrow mesenchymal stem cell (BMSC) transplantation repairs necrotic myocardium and improves cardiac function. Recent reports have shown that the laser has promotion effects on BMSCs in treatment of ischemic myocardium. OBJECTIVE: To evaluate superiority of autologous BMSC transplantation combined with transmyocardial laser revascularization (TMR) for treating acute myocardial ischemia in rabbits. DESIGN, TIME AND SETTING: The randomized controlled animal study was performed at the Laboratory of Surgery, Anzhen Hospital from January to July 2006. MATERIALS: A total of 32 adult male New Zealand rabbits were equally and randomly assigned into model control, cell transplantation, laser, and combination groups. METHODS: Bone marrow was obtained from rabbits by bilateral tibia puncture 3 days before model establishment. BMSCs were isolated, purified by density gradient centrifugation and medium change method, and then labeled with BrdU. In each group, anterior descending coronary artery of rabbits was ligated under general anesthesia to create acute myocardial ischemia models. 2 weeks later, rabbit models were injected with 0.5 mL α-MEM medium through three points in the model control group. The same volume of the fourth passage of BMSC suspension was injected into rabbits in the cell transplantation group, about 3× 10^6 cells. Rabbits in the laser group were treated with TMR using high power CO2 apparatus, perforating 3 holes, at the power of 5 J. Rabbits in the combination group were treated with TMR, and then infused with an equal volume of cell suspension in the middle layer of myocardium surrounding the hole channel. MAIN OUTCOME MEASURES: Four weeks after treatment, the left ventricular myocardium of all sacrificing animals was harvested, and then the immunohistochemistrial sections were stained by anti-BrdU and anti-TnT to identify the survival or differentiation of BMSCs, as well as the CD146^+ endothelial cells. Ultrasonicardiography (UCG) was performed to estimate cardiac function such as left ventricle ejection fraction, the displacement and strain of cardiac apex. RESULTS: Double stained positive cells were found, with black nuclei and brown cytoplasm in the cell transplantation and combination groups. Compared with the model control group, capillary vessel density significantly increased in the cell transplantation, laser and combination groups (P 〈 0.05), and the increase was significantly higher in the combination group than in the cell transplantation and laser groups (P 〈 0.05). The vascular density was similar between the cell transplantation and laser groups. Compared with pretreatment, ejection fraction value and the displacement or strain of cardiac apex was significantly improved at 4 weeks after treatment in the cell transplantation and combination groups (P 〈 0.05). There was significant difference in improvement of cardiac function compared with the model control and laser groups (P 〈 0.05). CONCLUSION: Autologous BMSCs from rabbits can differentiate into myocardium-like cells in myocardial microenvironment. Combining autologous BMSCs with TMR therapy has benefits of increasing myocardial capillary vessel density compared with BMSCs or TMR alone. The superiority in elevating cardiac function deserves further analysis.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2009年第19期3759-3764,共6页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献30

  • 1Leor J,Prentice H,Sartorelli V,et al.Gene transfer and cell transplant:an experimental approach to repair a 'broken heart'.Cardiovasc Res.1997;35(3):431-441.
  • 2Friedenstein AJ,Gorskaja JF,Kulagina NN.Fibroblast precursors in normal and irradiated mouse hematopoietic organs.Exp Hematol.1976;4(5):267-274.
  • 3Schuleri KH,Boyle A J,Hare JM Mesenchymal stem cells for cardiac regenerative therapy.Handb Exp Pharmacol.2007;(180):195-218.
  • 4Klein HM,Ghodsizad A,Borowski A,et al.Autologous bone marrow-derived stem cell therapy in combination with TMLR.A novel therapeutic option for endstage coronary heart disease:report on 2 cases.Heart Surg Forum.2004;7(5):E416-419.
  • 5国家科委.实验动物管理条例.1988.10-31
  • 6Celina M,Gonzalez,Manuel R,et al.Histopathologic time course of myocardial infarct in rabbit hearts.Cardiovascular Pathology.2002; 11 (6):339-345.
  • 7何振山,齐书英,候云生,李洁,崔俊玉.结扎兔冠脉4周后左室壁结构与室内压力的改变[J].心功能杂志,1998,10(3):148-150. 被引量:3
  • 8吕昌伟,胡蕴玉,白健萍.多样本骨髓间充质干细胞分离培养方法的量化比较[J].中国临床康复,2003,7(11):1636-1637. 被引量:17
  • 9王运涛.骨髓间充质干细胞成骨分化调控的研究进展[J].国外医学(生物医学工程分册),2003,26(1):29-34. 被引量:10
  • 10Menasche P,Hagege AA,Vilquin JT,et al.Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction.J A,Coll Cardiol.2003;41(7):1078-1083.

二级参考文献17

  • 1何振山,宁佩萸,于富军,卫亚利,高岩,贺江勇,杜静波.急性心肌梗死4周的左室重构[J].解放军医学杂志,1996,21(6):429-430. 被引量:18
  • 2何振山,卫亚利,于富军,高岩,贺江勇,杜静波.冠心病左室形态与功能多变量分析[J].数理医药学杂志,1997,10(1):22-24. 被引量:2
  • 3屈正,引进国外医药技术与设备,1998年,4期,81页
  • 4Symes JF, Losordo DW, Vale PR, et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease[J]. Ann Thorac Surg, 1999, 68:830~837.
  • 5Rosengart TK, Lee LY, Patel SR, et al. Angiogenesis gene therapy: phase Ⅰ assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease[J]. Circulation, 1999, 100:468~474.
  • 6Sayeed-Shah U, Mann MJ, Martin J, et al. Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization[J]. J Thorac Cardiovasc Surg, 1998, 116:763~769.
  • 7Horvath KA, Chiu E, Maun DC, et al. Up-regulation of vascular endothelial growth factor mRNA and angiogenesis after transmyocardial laser revascularization[J]. Ann Thorac Surg, 1999, 68:825~829.
  • 8Brilla CG, Rybinski L, Gehrke D, et al. Transmyocardial laser revascularization-an innovative pathophysiologic concept[J]. Herz, 1997, 22:183~189.
  • 9Fleischer KJ, Goldschmidt-Clermont PJ, Fonger JD, et al. One month histologic response of transmyocardial laser channels with molecular intervention[J]. Ann Thorac Surg, 1996, 62:1051~1058.
  • 10Sayeed-Shah U, Reul RM, Byrne JG, et al. Combination TMR and gene therapy[J]. Semin Thorac Cardiovasc Surg, 1999, 11:36~39.

共引文献72

同被引文献19

  • 1李占全,张明,金元哲,张薇薇,刘莹,袁龙,崔丽杰,刘显智,余宪,胡铁石.粒细胞集落刺激因子动员自体外周血干细胞移植治疗急性心肌梗死的临床研究[J].中华心血管病杂志,2006,34(2):99-102. 被引量:26
  • 2Hu X,Wang J,Chen J,et al.Optimal temporal dehvery of bone marrow mesenchymal stem cells in rats with myocardial infarction[J].Eur J Cardiothorac Surg,2007,31(3):438-443.
  • 3Nassiri S M,Khaki Z,Soleimani M,et al.The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation in duetion in experimental myocardial infarction[J].Biomed Sci,2007,14(6):745-755.
  • 4Stags M A,Coppen S R,Suzuki K,et al.Evaluation of frequency,type,and funetion of gap junctions between skeletal myoblasts over expressing connexin43 and cardiomyocytes:relevance to cell transplantation[J].FASEB,2006,20(6):744-746.
  • 5Schachinger V,Aasmus B,Honold J,et al.Normalization of coronary blood flow in the infarct-relied artery after intracoronary progenitor ceil therapy:intraeoronary Doppler sub Btudy of the TOPCARE-AMI trial[J].Clin Res Cardiol,2006,95(1):13-22.
  • 6Numaguchi Y,Sone T,Okumura K,et al.The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction[J].Circulafion,2006,114(1Suppl):S114-119.
  • 7Rachel R S,Baffle L,Cho H C,etal.Cardiogenicity and regenerative potential of cardiac-derived stem cells isolated from adult human and porcine endomyocardial biopsy specimens[J].Circulation,2006,114:11-51.
  • 8杨庆有,陆曙,苏伟,赵立诚.益气温阳活血方动员骨髓干细胞治疗大鼠急性心肌梗死的实验研究[J].中国实验方剂学杂志,2008,14(2):55-57. 被引量:7
  • 9金波,杨云贵,施海明,罗心平,李勇,孙宇立,李剑,沈伟.经冠状动脉自体骨髓单个核细胞移植治疗急性前壁心肌梗死:12个月疗效评价[J].中国组织工程研究与临床康复,2008,12(12):2267-2271. 被引量:2
  • 10杨敏,陈广玲,陈畅,张钰,闫纯英.人参皂甙Rg1可促进大鼠心肌梗死后心肌再生[J].心脏杂志,2008,20(6):697-700. 被引量:3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部